Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure?

American Heart Journal

Volumn 148, Issue 2, 2004, Pages 349-355

  De Groote, Pascal ^a   Soudan, Benoît ^b   Lamblin, Nicolas ^a   Rouaix Emery, Nathalie ^a   Mc Fadden, Eugène ^c   Meurice, Thibaut ^a   Mouquet, Frédéric ^a   Bauters, Christophe ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Clinique Linquette   (France)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NORADRENALIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW UP; HEART ATRIUM; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SURVIVAL RATE;

ATRIAL NATRIURETIC FACTOR; EXERCISE; EXERCISE TEST; FOLLOW-UP STUDIES; HEART ATRIA; HEART FAILURE, CONGESTIVE; HUMANS; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NORDEFRIN; OXYGEN; PROGNOSIS; RISK ASSESSMENT; STROKE VOLUME; SURVIVAL ANALYSIS;

EID: 4143086002     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.03.044     Document Type: Article

References (26)

1. Francis G.S., Benedict C., Johnstone D.E., et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 82:1990;1724-1729
2. Rouleau J.L., Packer M., Moye L., et al. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction effect of captopril. J Am Coll Cardiol. 24:1994;583-591
3. Benedict C.R., Shelton B., Johnstone D.E., et al. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators. Circulation. 94:1996;690-697
4. Cohn J.N., Johnson G.R., Shabetai R., et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation. 87:1993;VI5-16
5. Gottlieb S.S., Kukin M.L., Ahern D., et al. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol. 13:1989;1534-1539. [published erratum appears in J Am Coll Cardiol 1989;14:812]
6. Tsutamoto T., Wada A., Maeda K., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 96:1997;509-516
7. Pousset F., Isnard R., Lechat P., et al. Prognostic value of plasma endothelin-1 in patients with chronic heart failure. Eur Heart J. 18:1997;254-258
8. Pacher R., Stanek B., Hulsmann M., et al. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. J Am Coll Cardiol. 27:1996;633-641
9. Isnard R., Pousset F., Trochu J.N., et al. Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure. Am J Cardiol. 86:2000;417-421
10. Mancini D.M., Eisen H., Kussmaul W., et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 83:1991;778-786
11. Stelken A.M., Younis L.T., Jennison S.H., et al. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol. 27:1996;345-352
12. Matsumoto A., Hirata Y., Momomura S., et al. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. Am Heart J. 129:1995;139-145
13. Steele I.C., McDowell G., Moore A., et al. Response of atrial natriuretic peptide and brain natriuretic peptide to exercise in patients with chronic heart failure and normal control subjects. Eur J Clin Invest. 27:1997;270-276
14. Wijbenga J.A.M., Balk A.H.M.M., Boomsma F., et al. Cardiac peptides differ in their response to exercise implications for patients with heart failure in clinical practice. Eur Heart J. 20:1999;1424-1428
15. Friedl W., Mair J., Thomas S., et al. Relationship between natriuretic peptides and hemodynamics in patients with heart failure at rest and after ergometric exercise. Clin Chim Acta. 281:1999;121-126
16. Kato M., Kinugawa T., Ogino K., et al. Augmented response in plasma brain natriuretic peptide to dynamic exercise in patients with left ventricular dysfunction and congestive heart failure. J Int Med. 248:2000;309-315
17. Mc Nairy M., Gardetto N., Clopton P., et al. Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure implications for outpatient monitoring with B-type natriuretic peptide. Am Heart J. 143:2002;406-411
18. de Groote P., Millaire A., Pigny P., et al. Plasma levels of atrial natriuretic peptide at peak exercise a prognostic marker of cardiovascular- related death and heart transplantation in patients with moderate congestive heart failure. J Heart Lung Transplant. 16:1997;956-963
19. Rocca H.P., Weilenmann D., Follath F., et al. Oxygen uptake kinetics during low level exercise in patients with heart failure relation to neurohormones, peak oxygen consumption, and clinical findings. Heart. 81:1999;121-127
20. Krüger S., Graf J., Kunz D., et al. Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol. 40:2002;718-722
21. de Groote P., Millaire A., Vantyghem M.C., et al. Response of atrial natriuretic factor to surgical pericardial drainage in patients with chronic pericardial effusion. Int J Cardiol. 46:1994;15-22
22. Omland T., Aakvaag A., Bonarjee V.V., et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation. 93:1996;1963-1969
23. McCullough P.A., Nowak R.M., McCord J., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure analysis from Breathing Not Properly (BNP) multinational study. Circulation. 106:2002;r1-7
24. Logeart D., Saudubray C., Beyne P., et al. Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. J Am Coll Cardiol. 40:2002;1794-1800
25. Troughton R.W., Frampton C.M., Yandle T.G., et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet. 355:2000;1126-1130
26. Shen W.F., Tribouilloy C., Rey J.L., et al. Prognostic significance of Doppler-derived left ventricular diastolic filling variables in dilated cardiomyopathy. Am Heart J. 124:1992;1524-1533